360 related articles for article (PubMed ID: 22801352)
1. The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.
Krishnan AV; Swami S; Feldman D
Steroids; 2012 Sep; 77(11):1107-12. PubMed ID: 22801352
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling.
Krishnan AV; Swami S; Feldman D
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):343-8. PubMed ID: 20156557
[TBL] [Abstract][Full Text] [Related]
3. Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and prevention.
Krishnan AV; Swami S; Feldman D
J Steroid Biochem Mol Biol; 2013 Jul; 136():289-95. PubMed ID: 22939886
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice: selective modulation of aromatase expression in vivo.
Swami S; Krishnan AV; Wang JY; Jensen K; Peng L; Albertelli MA; Feldman D
Horm Cancer; 2011 Jun; 2(3):190-202. PubMed ID: 21686077
[TBL] [Abstract][Full Text] [Related]
5. Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy.
Krishnan AV; Swami S; Peng L; Wang J; Moreno J; Feldman D
Endocrinology; 2010 Jan; 151(1):32-42. PubMed ID: 19906814
[TBL] [Abstract][Full Text] [Related]
6. Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer.
Swami S; Krishnan AV; Wang JY; Jensen K; Horst R; Albertelli MA; Feldman D
Endocrinology; 2012 Jun; 153(6):2576-87. PubMed ID: 22454149
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D mitigates the adverse effects of obesity on breast cancer in mice.
Swami S; Krishnan AV; Williams J; Aggarwal A; Albertelli MA; Horst RL; Feldman BJ; Feldman D
Endocr Relat Cancer; 2016 Apr; 23(4):251-64. PubMed ID: 26817629
[TBL] [Abstract][Full Text] [Related]
8. Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements.
Swami S; Krishnan AV; Peng L; Lundqvist J; Feldman D
Endocr Relat Cancer; 2013 Aug; 20(4):565-77. PubMed ID: 23744764
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D.
Krishnan AV; Feldman D
Annu Rev Pharmacol Toxicol; 2011; 51():311-36. PubMed ID: 20936945
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D.
Jeong Y; Swami S; Krishnan AV; Williams JD; Martin S; Horst RL; Albertelli MA; Feldman BJ; Feldman D; Diehn M
Mol Cancer Ther; 2015 Aug; 14(8):1951-61. PubMed ID: 25934710
[TBL] [Abstract][Full Text] [Related]
11. Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1α,25-dihydroxyvitamin D
Lundqvist J; Kirkegaard T; Laenkholm AV; Duun-Henriksen AK; Bak M; Feldman D; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2018 Mar; 177():171-178. PubMed ID: 28610873
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment.
Krishnan AV; Feldman D
Endocr Relat Cancer; 2010 Mar; 17(1):R19-38. PubMed ID: 19926709
[TBL] [Abstract][Full Text] [Related]
13. New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death.
Cepa M; Correia-da-Silva G; da Silva EJ; Roleira FM; Borges M; Teixeira NA
BMC Cell Biol; 2008 Jul; 9():41. PubMed ID: 18652661
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion.
Flanagan L; Packman K; Juba B; O'Neill S; Tenniswood M; Welsh J
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):181-92. PubMed ID: 12711002
[TBL] [Abstract][Full Text] [Related]
15. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
16. Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells.
Amanatullah DF; Tamaresis JS; Chu P; Bachmann MH; Hoang NM; Collyar D; Mayer AT; West RB; Maloney WJ; Contag CH; King BL
Breast Cancer Res; 2017 Nov; 19(1):121. PubMed ID: 29141657
[TBL] [Abstract][Full Text] [Related]
17. The role of vitamin D in cancer prevention and treatment.
Krishnan AV; Trump DL; Johnson CS; Feldman D
Endocrinol Metab Clin North Am; 2010 Jun; 39(2):401-18, table of contents. PubMed ID: 20511060
[TBL] [Abstract][Full Text] [Related]
18. Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor‑positive, human epidermal growth factor receptor 2‑positive breast cancer cells.
Lim ST; Jeon YW; Gwak H; Kim SY; Suh YJ
Mol Med Rep; 2018 Apr; 17(4):5581-5588. PubMed ID: 29436642
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D analog EB1089 inhibits aromatase expression by dissociation of comodulator WSTF from the CYP19A1 promoter-a new regulatory pathway for aromatase.
Lundqvist J; Hansen SK; Lykkesfeldt AE
Biochim Biophys Acta; 2013 Jan; 1833(1):40-7. PubMed ID: 23085504
[TBL] [Abstract][Full Text] [Related]
20. Relationship between aromatase and cyclooxygenases in breast cancer: potential for new therapeutic approaches.
Brueggemeier RW; Díaz-Cruz ES
Minerva Endocrinol; 2006 Mar; 31(1):13-26. PubMed ID: 16498361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
